PALISADE CAPITAL MANAGEMENT, LP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$1,731,705
-56.2%
509,325
-5.4%
0.05%
-54.3%
Q2 2023$3,957,372
-25.7%
538,418
+4.8%
0.10%
-27.1%
Q1 2023$5,323,704
-10.1%
513,871
+2.4%
0.14%
-9.4%
Q4 2022$5,924,746
-46.4%
501,672
-4.8%
0.16%
-49.2%
Q3 2022$11,061,000
-37.0%
526,989
-6.9%
0.31%
-34.2%
Q2 2022$17,571,000
-23.6%
566,080
+1.0%
0.48%
-10.0%
Q1 2022$23,010,000
-9.5%
560,409
-4.2%
0.53%
+2.7%
Q4 2021$25,428,000
-21.1%
584,957
-9.1%
0.52%
-26.7%
Q3 2021$32,218,000
-15.1%
643,464
+6.8%
0.70%
-17.9%
Q2 2021$37,950,000
-34.7%
602,480
-3.8%
0.86%
-37.3%
Q1 2021$58,159,000
+12.1%
625,969
+8.1%
1.37%
+2.9%
Q4 2020$51,879,000
+17.1%
579,009
+35.0%
1.33%
+1.0%
Q3 2020$44,316,000
+51.4%
428,875
+15.9%
1.31%
+41.1%
Q2 2020$29,264,000
+152.1%
370,050
+84.5%
0.93%
+127.1%
Q1 2020$11,607,000
+72.2%
200,602
+60.6%
0.41%
+114.7%
Q4 2019$6,739,000
+3252.7%
124,916
+1645.9%
0.19%
+2628.6%
Q2 2016$201,0007,1550.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders